| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500124 |
NSE Symbol : DRREDDY |
P/E(TTM) : 147.31 |
|
ISIN Demat : INE089A01031 |
Div & Yield% : 0.68 |
EPS(TTM) : 7.95 |
|
Book Value(₹) : 377.95 |
Market Cap(₹Cr) : 97,749.41 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 20,532.80 | 23,115.40 | 19,483.80 | 16,962.50 | 14,405.20 |
| Other Income | 1,689.60 | 1,003.40 | 862.30 | 591.30 | 482.00 |
| Stock Adjustments | 230.50 | 173.90 | 238.80 | -129.50 | 389.60 |
| Total Income | 22,452.90 | 24,292.70 | 20,584.90 | 17,424.30 | 15,276.80 |
| EXPENDITURE : | |||||
| Raw Materials | 6,968.30 | 6,239.60 | 5,278.10 | 4,940.70 | 5,435.50 |
| Power and Fuel Cost | 473.40 | 480.10 | 454.40 | 398.10 | 326.80 |
| Other Manufacturing Expenses | 1,683.80 | 1,949.80 | 1,556.00 | 1,257.90 | 1,038.90 |
| Selling and Administration Expenses | 3,695.50 | 3,500.00 | 3,064.60 | 2,782.80 | 2,672.90 |
| Miscellaneous Expenses | 475.00 | 450.50 | 357.40 | 406.10 | 292.00 |
| Employee Benefit Expenses | 3,549.90 | 3,287.50 | 3,085.70 | 2,832.60 | 2,434.60 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,607.00 | 8,385.20 | 6,788.70 | 4,806.10 | 3,076.10 |
| Interest | 148.30 | 109.90 | 21.80 | 16.90 | 38.00 |
| Gross Profit | 5,458.70 | 8,275.30 | 6,766.90 | 4,789.20 | 3,038.10 |
| Depreciation | 1,207.40 | 1,039.40 | 975.60 | 923.20 | 814.30 |
| Profit Before Tax | 4,251.30 | 7,235.90 | 5,791.30 | 3,866.00 | 2,223.80 |
| Current Tax | 917.70 | 1,790.50 | 1,361.80 | 864.10 | 392.60 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 113.90 | 96.00 | 87.50 | 389.10 | 208.00 |
| Reported Net Profit | 3,219.70 | 5,349.40 | 4,342.00 | 2,612.80 | 1,623.20 |
| Extraordinary Items | 157.07 | -31.64 | 57.81 | -15.75 | -5.69 |
| Adjusted Net Profit | 3,062.63 | 5,381.04 | 4,284.19 | 2,628.55 | 1,628.89 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 25,953.90 | 21,205.40 | 17,504.80 | 15,403.00 | 14,137.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 665.90 | 600.90 | 641.50 | 511.00 | 357.50 |
| P & L Balance carried down | 28,507.70 | 25,953.90 | 21,205.40 | 17,504.80 | 15,403.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 800.00 | 800.00 | 800.00 | 800.00 | 600.00 |
| Dividend Per Share(Rs) | 8.00 | 8.00 | 40.00 | 40.00 | 30.00 |
| Earnings Per Share-Unit Curr | 38.56 | 64.14 | 260.31 | 156.83 | 97.55 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 377.81 | 348.72 | 1,453.29 | 1,236.56 | 1,111.56 |
| Book Value(Adj)-Unit Curr | 377.81 | 348.72 | 290.66 | 247.31 | 222.31 |
